Kobo Biotech Limited (BOM:531541)
2.720
+0.010 (0.37%)
At close: May 19, 2025
Kobo Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Cash & Equivalents | - | 1.81 | 0.84 | 0.84 | 15.17 | 0.85 | Upgrade
|
Short-Term Investments | - | - | 0.43 | 0.43 | 0.43 | 0.43 | Upgrade
|
Cash & Short-Term Investments | 1.81 | 1.81 | 1.27 | 1.26 | 15.6 | 1.28 | Upgrade
|
Cash Growth | 42.20% | 42.20% | 0.47% | -91.90% | 1120.33% | -1.35% | Upgrade
|
Accounts Receivable | - | 119.65 | 119.52 | 117.96 | 924.72 | 932.86 | Upgrade
|
Other Receivables | - | - | - | - | 23.17 | 0.98 | Upgrade
|
Receivables | - | 119.65 | 119.52 | 117.96 | 947.88 | 941.74 | Upgrade
|
Inventory | - | 180.41 | 180.41 | 180.41 | 532.79 | 555.95 | Upgrade
|
Prepaid Expenses | - | - | 0.1 | 0.13 | 0.26 | 0.2 | Upgrade
|
Other Current Assets | - | 76.91 | 76.13 | 75.5 | 95.8 | 94.24 | Upgrade
|
Total Current Assets | - | 378.78 | 377.43 | 375.26 | 1,592 | 1,593 | Upgrade
|
Property, Plant & Equipment | - | 335.16 | 375.87 | 416.59 | 591.58 | 647.95 | Upgrade
|
Long-Term Investments | - | - | - | - | 121.93 | 121.93 | Upgrade
|
Other Long-Term Assets | - | - | - | - | -0 | - | Upgrade
|
Total Assets | - | 713.94 | 753.3 | 791.85 | 2,306 | 2,363 | Upgrade
|
Accounts Payable | - | 557.81 | 547.35 | 521.72 | 604.51 | 570.79 | Upgrade
|
Accrued Expenses | - | - | - | - | - | 113.16 | Upgrade
|
Short-Term Debt | - | 1,080 | 597.59 | 597.59 | 1,747 | 1,639 | Upgrade
|
Current Portion of Long-Term Debt | - | - | 474.23 | 474.23 | 522.68 | 519.06 | Upgrade
|
Current Income Taxes Payable | - | 2.09 | 1.94 | 1.8 | 3.74 | - | Upgrade
|
Other Current Liabilities | - | 38.56 | 37.74 | 37.78 | 113.37 | 0.45 | Upgrade
|
Total Current Liabilities | - | 1,678 | 1,659 | 1,633 | 2,992 | 2,843 | Upgrade
|
Long-Term Debt | - | 317.14 | 326.6 | 335.34 | 335.34 | 349.33 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 29.9 | 29.9 | 29.9 | 29.9 | 29.9 | Upgrade
|
Other Long-Term Liabilities | - | 17.77 | 17.77 | 17.77 | 21.08 | 21.08 | Upgrade
|
Total Liabilities | - | 2,043 | 2,033 | 2,016 | 3,378 | 3,243 | Upgrade
|
Common Stock | - | 238.25 | 238.25 | 238.25 | 238.25 | 238.25 | Upgrade
|
Additional Paid-In Capital | - | - | 317.05 | 317.05 | 317.05 | - | Upgrade
|
Retained Earnings | - | - | -1,844 | -1,789 | -1,636 | - | Upgrade
|
Comprehensive Income & Other | - | -1,567 | 9 | 9 | 9 | -1,118 | Upgrade
|
Shareholders' Equity | -1,329 | -1,329 | -1,280 | -1,224 | -1,072 | -879.71 | Upgrade
|
Total Liabilities & Equity | - | 713.94 | 753.3 | 791.85 | 2,306 | 2,363 | Upgrade
|
Total Debt | 1,397 | 1,397 | 1,398 | 1,407 | 2,605 | 2,508 | Upgrade
|
Net Cash (Debt) | -1,395 | -1,395 | -1,397 | -1,406 | -2,590 | -2,506 | Upgrade
|
Net Cash Per Share | -58.77 | -58.59 | -58.64 | -59.01 | -108.70 | -105.24 | Upgrade
|
Filing Date Shares Outstanding | 23.74 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | Upgrade
|
Total Common Shares Outstanding | 23.74 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | Upgrade
|
Working Capital | - | -1,299 | -1,281 | -1,258 | -1,399 | -1,249 | Upgrade
|
Book Value Per Share | -55.79 | -55.79 | -53.72 | -51.39 | -45.00 | -36.92 | Upgrade
|
Tangible Book Value | -1,329 | -1,329 | -1,280 | -1,224 | -1,072 | -879.71 | Upgrade
|
Tangible Book Value Per Share | -55.79 | -55.79 | -53.72 | -51.39 | -45.00 | -36.92 | Upgrade
|
Land | - | - | 23.65 | 23.65 | 23.65 | 31.33 | Upgrade
|
Buildings | - | - | 188.59 | 188.59 | 188.59 | 188.59 | Upgrade
|
Machinery | - | - | 816.84 | 816.84 | 1,704 | 1,704 | Upgrade
|
Construction In Progress | - | - | - | - | 22.51 | 22.51 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.